In older mice, a treatment using tiny particles derived from stem cells, delivered through the nose, leads to better performance in memory tests that measure the ability to recognize new objects and...

From: Intranasal Human NSC‐Derived EVs Therapy Can Restrain Inflammatory Microglial Transcriptome, and NLRP3 and cGAS‐STING Signalling, in Aged Hippocampus

Strongly contradicted

Multiple high-quality studies challenge this claim.

0
Pro
17
Against
causal
1 study

Not medical advice. For informational purposes only. Always consult a healthcare professional.

What this claim means

In older mice, a treatment using tiny particles derived from stem cells, delivered through the nose, leads to better performance in memory tests that measure the ability to recognize new objects and...

See the technical phrasing

In aged mice, intranasal administration of human induced pluripotent stem cell-derived neural stem cell extracellular vesicles improves recognition and spatial memory, as evidenced by significantly greater preference for novel stimuli in novel object recognition and object location tests compared to vehicle-treated controls.

Why this might work
Verified
based on 1 study

Tiny particles from stem cells, delivered through the nose, enter the brain and calm down overactive immune cells in the memory center. This reduces harmful chemicals and stress inside brain cells, which lets neurons and their connections work better. As a result, the mouse can remember where objects were and recognize new ones.

What the research says

Supports

0 studies

0

Contradicts

1 study

17

Study: Intranasal Human NSC‐Derived EVs Therapy Can Restrain Inflammatory Microglial Transcriptome, and NLRP3 and cGAS‐STING Signalling, in Aged Hippocampus

This study provides evidence contradicting the claim.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.